Spliceosomal introns are noncoding DNA sequences located between exons in many eukaryotic protein-coding genes. Most are removed post-transcriptionally by RNA splicing and do not encode proteins, but ...
Australia's All G has debuted its precision-fermented bovine lactoferrin in the US as it plans a second facility and expects ...
The Northwestern facility will be the nation’s first open automated lab for designing, building, and testing proteins.
The study brought together researchers from Brazil, Canada, Chile, Colombia and India to test whether laboratories across ...
Protein production in insect cells or in whole insects could move past the trade-off long associated with conventional ...
Automated, detergent-free purification preserves native membrane protein structure while supporting more reliable target ...
Patent expands intellectual property protection in one of the world's largest cartilage repair marketsGelrinC is a cell-free hydrogel delivered in a single ~10-minute procedure eliminating the need fo ...
Patent expands intellectual property protection in one of the world's largest cartilage repair marketsGelrinC is a ...
The FDA has approved Lipfendra, the first oral PCSK9 inhibitor, for the treatment of high cholesterol. Two medical experts explain why this matters.
Inhibrx is transitioning from a platform to a clinical-stage biotech, with ozekibart and INBRX-106 as key value drivers.
When antibiotics attack microbes, their stressed neighbors ship them proteins to help them survive, new work suggests.
Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) has accepted a New Drug Application (NDA) for mezigdomide in combination with carfilzomib and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results